ÇòʸĻ¥Ô¥Ômeʪ¸ì

¸¡»¡¤ÈÂç¼ê¥á¥Ç¥£¥¢¤ÎÌÀ¤é¤«¤ÊÈȺá

Á´ÂÎɽ¼¨

[ ¥ê¥¹¥È ]


¥¨¥Ü¥éÇ®¥¦¥¤¥ë¥¹¤Ë´Ø¤·¤Æ£²£°£±£°Ç¯ÆÃµö¤ò¤È¤Ã¤Æ¤¤¤ëÊÆ¹ñ¤¬¥ï¥¯¥Á¥ó¤ÇÂçÌÙ¤±¤·¡¢Â¾Êý¡¢¥¢¥Õ¥ê¥«¤Î¿Í¸ý¤òºï¸º¤·¤è¤¦¤È¤Î´ë¤ß¡£

À¾¥¢¥Õ¥ê¥«¤Î½»Ì±¤Ë¥¨¥Ü¥éÇ®¥¦¥¤¥ë¥¹¤òÃí¼Í¤·¡¢´µ¼Ô¤ò°ìµ¤¤ËÁý¤ä¤·¡¢¹ñºÝ¶âÍ»»ñËܤλÙÇÛ¤¹¤ë¹ñÏ¢¤ÈWHO¤ÇÂçÁû¤®¤µ¤»¡¢À¤³¦³Æ¹ñ¤Ë¥ï¥¯¥Á¥ó¤òÇã¤ï¤»¤ëº²ÃÀ¡£

¡ÊÁ°²ó¤Î»ä¤Î¥Ö¥í¥°µ­»ö¡Ë
¥¨¥Ü¥é¤Ï°äÅÁ»ÒÁȤߴ¹¤¨¤Î¥Ð¥¤¥ªÊ¼´ï¡¡¡¡2014/10/17(¶â)




Ebola infections outpacing health authorities¡Ç efforts: UN official
October 15, 2014 | 4:31am

ÊÝ·òµ¡´Ø¤ÎÅØÎϤòÄɤ¤±Û¤¹¥¨¥Ü¥éÅÁÀ÷É¡§¹ñÏ¢
£²£°£±£´Ç¯£±£°·î£±£µÆü¡¡NEW¡¡YORK¡¡POST

The United Nations warned Tuesday that the world has less than 60 days to stem the deadly Ebola epidemic 

¹ñÏ¢¤Ï¡¢Ã×̿Ū¤Ê¥¨¥Ü¥é¤Îή¹Ôɤò»ß¤á¤ë¤¿¤á¤Ë¡¢Í±Í½¤Ï60Æü´Ö¤·¤«¤Ê¤¤¤È²ÐÍËÆü¤Ë·Ù¹ð¤·¤Þ¤·¤¿¡£¡Ê°Ê²¼¾Êά¡Ë

¡ÊÃí¡ËÀ¤³¦¤ò¶²Éݤ˴٤ì¤ë¤Î¤¬ºÇ¤â¸ú²ÌŪ¤ÊÀëÅÁÊýË¡¡£


¥¨¥Ü¥é¥ï¥¯¥Á¥ó¡¢À½Ìô²ñ¼Ò¤¬Íèǯ¾å´ü¤ÎÂçÉýÁý»º¤ØÃíÎÏ¡á£×£È£Ï¡¡
2014ǯ 10·î 2Æü 06:06 JST

¡Î¥¸¥å¥Í¡¼¥Ö¡¡£±Æü¡¡¥í¥¤¥¿¡¼¡Ï - À¤³¦ÊÝ·òµ¡´Ø¡Ê£×£È£Ï¡Ë¤Ï£±Æü¡¢¥¨¥Ü¥é½Ð·ìÇ®Âкö¤Ë¤Ä¤¤¤Æ¡¢±Ñ¥°¥é¥¯¥½¡¦¥¹¥ß¥¹¥¯¥é¥¤¥ó(GSK.L: ³ô²Á, ´ë¶È¾ðÊó, ¥ì¥Ý¡¼¥È)¤ÈÊÆ¥Ë¥å¡¼¥ê¥ó¥¯¡¦¥¸¥§¥Í¥Æ¥£¥¯¥¹(NLNK.O: ³ô²Á, ´ë¶È¾ðÊó, ¥ì¥Ý¡¼¥È)¤¬Ì¤¾µÇ§¥ï¥¯¥Á¥ó¤ÎÀ¸»ºÇ½ÎϳÈÂç¤Ë¼è¤êÁȤó¤Ç¤ª¤ê¡¢£²£°£±£µÇ¯¾å´ü¤ÎÂçÉýÁý»º¤òÌܻؤ·¤Æ¤¤¤ë¤ÈÌÀ¤é¤«¤Ë¤·¤¿¡£¡Ê°Ê²¼¾Êά¡Ë



¥¨¥Ü¥éÇ®¤Î¥ï¥¯¥Á¥ó³«È¯¡¢µÞ®¤Ë¿Ê¤ó¤Ç¤¤¤ë¡á±Ñ£Ç£Ó£Ë
2014ǯ 10·î 20Æü 08:44 JST

¡Î¥í¥ó¥É¥ó¡¡£±£¸Æü¡¡¥í¥¤¥¿¡¼¡Ï - ±ÑÀ½ÌôÂç¼ê¥°¥é¥¯¥½¡¦¥¹¥ß¥¹¥¯¥é¥¤¥ó¡Ê£Ç£Ó£Ë¡Ë ¤Ï£±£¸Æü¡¢¥¨¥Ü¥é½Ð·ìÇ®¤Î¥ï¥¯¥Á¥ó³«È¯¤ÏµÞ®¤Ë¿Ê¤ó¤Ç¤¤¤ë¤È¤Î¸«Êý¤ò¼¨¤·¤¿¡£

£Ç£Ó£Ë¤Ï¥¦¥§¥Ö¥µ¥¤¥È¤Ë·ÇºÜ¤·¤¿À¼ÌÀ¤Ç¡Ö¥ï¥¯¥Á¥ó¸õÊäÉʤγ«È¯¤Ï¤«¤Ä¤Æ¤Ê¤¤Â®¤µ¤Ç¿Ê¤ó¤Ç¤¤¤ë¡£Â裱Ãʳ¬¤Î°ÂÁ´À­»î¸³¤ÏÊÆ¹ñ¡¢±Ñ¹ñ¤È¥Þ¥ê¤Ç¼Â»ÜÃæ¤Ç¡¢Íè½µ°Ê¹ß¤â¾¹ñ¤Ç³«»Ï¤¹¤ë¡×¤ÈÀâÌÀ¤·¤¿¡£

Ʊ¼Ò¤Ë¤è¤ë¤È¡¢Â裱Ãʳ¬¤Î½é´ü¥Ç¡¼¥¿¤ÏǯÆâ¤ËÆÀ¤é¤ì¤ë¸«¹þ¤ß¤Ç¡¢À®¸ù¤·¤¿¾ì¹ç¤Ë¤Ï£²£°£±£µÇ¯Á°È¾¤Ë¼¡Ãʳ¬¤Î»î¸³¤ò»Ï¤á¤ë¡£¤³¤ì¤Ë¤Ï¥·¥¨¥é¥ì¥ª¥Í¡¢¥®¥Ë¥¢¡¢¥ê¥Ù¥ê¥¢¤Î¸½¾ì°åÎÅ´Ø·¸¼Ô¤Ø¤Î¥ï¥¯¥Á¥óÀܼï¤â´Þ¤Þ¤ì¤ë¤È¤¤¤¦


ÉٻΥե¤¥ë¥à¤Î¥¨¥Ü¥é̤¾µÇ§Ìô¡¢¥Î¥í¥¦¥£¥ë¥¹¤Ë¤âÍ­¸ú¤«¡á±ÑÂç³Ø
2014ǯ 10·î 22Æü 01:08 JST

¡Î¥í¥ó¥É¥ó¡¡£²£±Æü¡¡¥í¥¤¥¿¡¼¡Ï - ¥¨¥Ü¥é½Ð·ìÇ®¤Ø¤Î¸ú²Ì¤¬´üÂÔ¤µ¤ì¤ëÉٻΥե¤¥ë¥à(4901.T: ³ô²Á, ¥Ë¥å¡¼¥¹, ¥ì¥Ý¡¼¥È)¤Î¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¼£ÎÅÌô¡Ö¥¢¥Ó¥¬¥ó¡Ê°ìÈÌ̾¥Õ¥¡¥Ó¥Ô¥é¥Ó¥ë¡Ë¡×¤Ë¤Ä¤¤¤Æ¡¢±Ñ¥±¥ó¥Ö¥ê¥Ã¥¸Âç³Ø¤Î¸¦µæ¥Á¡¼¥à¤Ï£²£±Æü¡¢¥Î¥í¥¦¥£¥ë¥¹¤ËÂФ·¤Æ¤â¸ú²Ì¤òȯ´ø¤¹¤ë²ÄǽÀ­¤¬¤¢¤ë¤È¤Î¸«²ò¤ò¼¨¤·¤¿¡£¡Ê°Ê²¼¾Êά¡Ë

¡ÊÃí¡ËÊÆ¹ñ¤Ë¤È¤Ã¤ÆÉٻΥե¤¥ë¥à¤ÎÌô¤¬¸ú¤¯¤È¤ÏÁÛÄê³°¡£
²¿¤é¤«¤Î»Å³Ý¤±¤ò¤·¤Æ¤¯¤ë¤À¤í¤¦¡£Î㤨¤ÐÆÃµö¿¯³²Áʾ٤Ȥ«¡£



À¤³¦¤ò¶²Éݤ˴٤餻¤ë¤¿¤á¤Ëºî¤Ã¤¿±ÇÁü¤Ï¥¤¥ó¥Á¥­¤Ç¤¢¤ë¤³¤È¤¬Ë½Ïª¤µ¤ì¤ë¡£

À¤³¦³ÆÔ¢¤Ë¥ï¥¯¥Á¥ó¤òÇä¤ë°Ù¤Ë¤ªÆÀ°Õ¤Î¤ä¤é¤»±ÇÁü¤¬ÁϤé¤ì¡¢Á´À¤³¦¤ËÇÛÉÛ¡£
¤³¤ì¡¢ÂçÅì°¡ÀïÁè¤Î»þ¤â¡¢Â¾¤ÎÀïÁè¤Î±ÇÁü¤ä¡¢¤ä¤é¤»¤Î±ÇÁü¤òÁϤꡢÆüËÜ·³¤Ï»ÄµÔÈ󯻤ÈÊÆ¹ñÆâ¤Î¤ß¤Ê¤é¤ºÀ¤³¦¤ËÇÛ¿®¤·¤¿¤Î¤ÈƱ¤¸¤ä¤ê¸ý¡£

¡Ê¤½¤Î£±¡Ë
Â礲¤µ¤Ë¥¨¥Ü¥é´µ¼Ô¤Î±ÇÁü¤ò»£±Æ¤µ¤»¤¿¸å¡Ê¡©¡ËÈô¹Ôµ¡¤Ë¾è¤»¤è¤¦¤È¤·¤Æ¤¤¤ë¡£
ï¤â¸«¤Æ¤¤¤Ê¤¤¤È»×¤Ã¤¿¤Î¤Ç¤·¤ç¤¦¤«¡©
»Ø¿Þ¤·¤Æ¤¤¤ëÃˤÏ̵ËÉÈ÷¡£

¥æ¡¼¥Á¥å¡¼¥Ö¡¡¡¡http://youtu.be/l7onTX5HpEw
イメージ 1

¥¨¥Ü¥é´µ¼Ô¤òÈô¹Ôµ¡¤Ë¾è¤»¤¿¸å¡¢Èà¤âÈô¹Ôµ¡¤ËÅë¾è¡£
イメージ 2


¡Ê¤½¤Î£²¡Ë¥¨¥Ü¥é¤ÎÀìÌç²È¤Ç¤â¤Ê¤¤Ãˤ¬ÌµËÉÈ÷¤ÇTV¤Î¥ì¥Ý¡¼¥¿¡¼¡£
¥æ¡¼¥Á¥å¡¼¥Ö¡¡¡¡http://youtu.be/s6VeI_6scfc
イメージ 3


¡Ê¤½¤Î£³¡ËCNN¥Ë¥å¡¼¥¹¡£·ò¹¯¤½¤¦¤ÊÃˤ¬µßµÞ¼Ö¤Î¸å¤í¤Ç²£¤¿¤ï¤Ã¤Æ¤¤¤ë¡£
¥æ¡¼¥Á¥å¡¼¥Ö¡¡CNN: Inside Liberia's Ebola crisis
イメージ 4


°Õ¼±Åª¤ËÍî¤Á¤Æ¡¢Æ»Ï©¤ËÅݤ줿³Ê¹¥¤Ç²£¤¿¤ï¤ë¡£
¤½¤³¤Ç¼Ö¤ò¤Î¤±¤Æ¡¢¤¤¤«¤Ë¤â½»Ì±¤¬¥¨¥Ü¥é¤ÇÆ»¤ËÅÝ¤ì¤Æ¤¤¤¿¤È¤Î±ÇÁü¤òºî¤ë¡£
イメージ 5



¡Ê¤½¤Î£´¡Ë¤³¤ì¤âCNN¥Ë¥å¡¼¥¹¡£¸þ¤³¤¦¤«¤é»Ò¶¡¤¬¸µµ¤¤ËÊ⤤¤Æ¤¯¤ë¡£
¥æ¡¼¥Á¥å¡¼¥ÖURL¤Ï¡Ê¤½¤Î£³¡Ë¤ÈƱ¤¸¡£
イメージ 6

½è¤¬¡¢»ØÄê¾ì½ê¤ËÍè¤ë¤È¡¢Åݤ줿³Ê¹¥¤Ç¿²Å¾¤Ö¡£
¤³¤ì¤â¾åµ­µßµÞ¼Ö¤«¤é³ê¤êÍî¤Á¤¿Âç¿Í¤ÈƱ¤¸¤¯¡¢¥¨¥Ü¥é¤ÇÅݤ줿¤È¤Î±ÇÁü¤òºî¤ë¡£
イメージ 7




¡ÊÊÆ¹ñ¤Î¥¨¥Ü¥é¥¦¥¤¥ë¥¹ÆÃµö¡Ë

¤Ä¤Þ¤ê¡¢¥¨¥Ü¥é¥¦¥¤¥ë¥¹¤Î¥ï¥¯¥Á¥ó¤äÌô¤Ï¡¢Á´¤ÆÆÃµö»ÈÍÑÎÁ¤ò»Ùʧ¤ï¤Ê¤±¤ì¤Ð¤Ê¤é¤Ê¤¤¡£Éµ¤¤òÌ¢±ä¤µ¤»¤ëÄø¡¢¼«Æ°Åª¤ËÌÙ¤«¤ë»ÅÁȤߡ£

⤷¡¢ÆüËܤÎÉٻΥե¤¥ë¥à¤¬Â¤¤Ã¤¿¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¼£ÎÅÌô¡Ö¥¢¥Ó¥¬¥ó¡Ê°ìÈÌ̾¥Õ¥¡¥Ó¥Ô¥é¥Ó¥ë¡Ë¡×¤â¤½¤ÎÂоݤȤʤ뤫¤É¤¦¤«¤ÏÉÔÌÀ¡£



°Ê²¼¡¢ÆÃµöÆâÍÆ¤Î°ìÉôÈ´¿è¡£
Ãí¡ËËÝÌõ¤¬²¼¼ê¤Ç¤¹¤Î¤Çͽ¤á¤´Î»¾µ²¼¤µ¤¤¡£


Human ebola virus species and compositions and methods thereof
CA 2741523 A1

¥Ò¥È¥¨¥Ü¥é¥¦¥¤¥ë¥¹¼ï¤ª¤è¤Ó¤½¤ì¤é¤ÎÁÈÀ®Êª¤ª¤è¤ÓÊýË¡

Í×Ìó½ñ
Compositions and methods including and related to the Ebola Bundibugyo virus (EboBun) are provided. 

Bundibugyo¡Ê¥¦¥¬¥ó¥À¤Î¥Ö¥ó¥Ç¥£¥Ö¥®¥ç¸© ¡Ë¤ÇºÎ¼è¤µ¤ì¤¿¥¨¥Ü¥é¥¦¥¤¥ë¥¹¡ÊEboBun¡¢Î¬¾Î¡Ë¤ò´Þ¤ß¡¢¤½¤·¤Æ¤½¤ì¤Ë´ØÏ¢¤·¤¿ÁÈÀ®Êª¤ª¤è¤ÓÊýË¡¤¬Ä󶡤µ¤ì¤ë¡£ 

Compositions are provided that are operable as immunogens to elicit and immune response or protection from EboBun challenge in a subject such as a primate.

¹çÀ®Êª¤Ï¡¢ÎîĹưʪ¤Î¤è¤¦¤Ê´µ¼Ô¤Ë»É·ã¤·¡¡¥¨¥Ü¥é¥¦¥¤¥ë¥¹¡ÊEboBun¡Ë¤«¤éÌȱ֤äÊݸ¤ë¤¿¤á¤ÎÌȱָ¶¤ÈƱÍÍ¡¢¼Â»Ü²Äǽ¤Ê¤â¤Î¤ÇÄ󶡤µ¤ì¤ë¡£ 


Inventive methods are directed to detection and treatment of EboBun infection.
ËÜȯÌÀ¤ÎÊýË¡¤Ï¥¨¥Ü¥é¥¦¥¤¥ë¥¹¡ÊEboBun¡Ë´¶À÷¤Î¸¡½Ð¤ª¤è¤Ó¼£ÎŤ˸þ¤±¤é¤ì¤Æ¤¤¤ë¡£


¸ø¹ðÈÖ¹æ CA2741523 A1
¸ø³«¥¿¥¤¥× ½Ð´ê
½Ð´êÈÖ¹æ CA 2741523
PCT ÈÖ¹æ PCT/US2009/062079
¸ø³«Æü 2010ǯ4·î29Æü
½Ð´êÆü 2009ǯ10·î26Æü
Í¥ÀèÆü 2008ǯ10·î24Æü
¼¡¤ÎÈÖ¹æ¤Ç¤â¸ø³« EP2350270A2, ¾ 4 ·ï »
ȯÌÀ¼Ô Jonathan S. Towner, ¾ 4 ·ï »
ÆÃµö½Ð´ê¿Í Jonathan S. Towner, ¾ 5 ·ï »
°úÍѤΥ¨¥¯¥¹¥Ý¡¼¥È BiBTeX, EndNote, RefMan
ʬÎà (21), ˡŪ¤Ê¥¤¥Ù¥ó¥È (1)
³°Éô¥ê¥ó¥¯:  CIPO, Espacenet


ÌÀºÙ½ñ  ¡ÊOCR ¥Æ¥­¥¹¥È¤Ë¤Ï¸í¤ê¤¬´Þ¤Þ¤ì¤Æ¤¤¤ë¾ì¹ç¤¬¤¢¤ê¤Þ¤¹¡Ë
HUMAN EBOLA VIRUS SPECIES AND COMPOSITIONS AND METHODS THEREOF¡¡¡ÊÃæÎ¬¡Ë

¿Í¥¨¥Ü¥é¥¦¥¤¥ë¥¹¼ï¤ª¤è¤ÓÁÈÀ®Êª¤ª¤è¤Ó¤½¤Î»ÈÍÑÊýË¡

¡Ú0009] The present invention is based upon the isolation and identification of a new human Ebola virus species, EboBun.

 ¡Ú0009¡ÛËÜȯÌÀ¤Ï¡¢¿·¤¿¤Ê¿Í´Ö¤Î¥¨¥Ü¥é¥¦¥¤¥ë¥¹¼ï¡¢EboBun¤ÎñΥ¤ª¤è¤ÓƱÄê¤Ë´ð¤Å¤¤¤Æ¤¤¤ë¡£


EboBun was isolated from the patients suffering from hemorrhagic fever in a recent outbreak in Uganda.

EboBun¤Ï¥¦¥¬¥ó¥À¤Ç¤ÎºÇ¶á¤Îή¹Ô¤Ç½Ð·ìÇ®¤ËØí´µ¤·¤Æ¤¤¤ë´µ¼Ô¤«¤éñΥ¤·¤¿¡£

¡ÊÃæÎ¬¡Ë

[0037] Due to the sequence divergence of EboBun relative to all previously recognized ebolaviruses, the present invention has utility in design of diagnostic assays to monitor Ebola HF

¡Ú0037¡Û¤¹¤Ù¤Æ¤Î°ÊÁ°¤Ëǧ¼±ebolaviruses¤ËEboBun¤ÎÁêÂÐŪ¤ÊÇÛÎó¤ÎÁê°ã¤Ëµ¯°ø¤·¤Æ¡¢ËÜȯÌÀ¤Ï¡¢¥¨¥Ü¥éHF¤ò´Æ»ë¤¹¤ë¤¿¤á¤Î¿ÇÃÇʬÀϤÎÀ߷פˤª¤¤¤ÆÍ­ÍÑÀ­¤òÍ­¤¹¤ë 

disease in humans and animals, and develop effective antivirals and vaccines
¥Ò¥È¤ª¤è¤Óưʪ¤Ë¤ª¤±¤ë¼À´µ¡¢¤ª¤è¤Ó¡¢¸ú²ÌŪ¤Ê¹³¥¦¥¤¥ë¥¹ºÞ¤ª¤è¤Ó¥ï¥¯¥Á¥ó¤ò³«È¯¤¹¤ë¡£
¡ÊÃæÎ¬¡Ë

[0110] The invention provides vaccine formulations for the prevention and treatment of infections with hEbola virus.
n certain embodiments, the vaccine of the invention comprises recombinant and chimeric viruses of the hEbola virus.
In certain embodiments, the virus is attenuated.

¡Ú0110¡ÛËÜȯÌÀ¤Ï¡¢hEbola¥¦¥¤¥ë¥¹¤Ë¤è¤ë´¶À÷¾É¤ÎͽËɤª¤è¤Ó¼£ÎŤΤ¿¤á¤Î¥ï¥¯¥Á¥óÀ½ºÞ¤òÄ󶡤¹¤ë¡£ ÆÃÄê¤Î¼Â»Ü·ÁÂ֤ˤª¤¤¤Æ¡¢ËÜȯÌÀ¤Î¥ï¥¯¥Á¥ó¤Ï¡¢hEbola¥¦¥¤¥ë¥¹¤ÎÁÈ´¹¤¨¤ª¤è¤Ó¥­¥á¥é¥¦¥¤¥ë¥¹¤ò´Þ¤à¡£ ÆÃÄê¤Î¼Â»Ü·ÁÂ֤Ǥϡ¢¥¦¥¤¥ë¥¹¤Ï¼åÆÇ²½¤µ¤ì¤Æ¤¤¤ë¡£ 

[0111] In another embodiment of this aspect of the invention, inactivated vaccine formulations are prepared using conventional techniques to "kill" the chimeric viruses.

¡Ú0111¡ÛËÜȯÌÀ¤Î¤³¤ÎÂÖÍͤÎÊ̤μ»ܷÁÂ֤Ǥϡ¢ÉԳ貽¥ï¥¯¥Á¥óÀ½ºÞ¤Ï¡¢¥­¥á¥é¥¦¥¤¥ë¥¹¤ò¡Ö»àÌǤµ¤»¤ë¡×¤¿¤á¤Î½¾Íè¤Îµ»½Ñ¤òÍѤ¤¤ÆÄ´À½¤µ¤ì¤ë¡£ ¡Ê°Ê²¼¾Êά¡Ë

¡Ê¸¶Ê¸¡Ë



¡Ö¢¡¹ñºÝ¶âÍ»»ñËܡ׽ñ¸Ë¤Îµ­»ö°ìÍ÷

ÊĤ¸¤ë ¥³¥á¥ó¥È¡Ê4¡Ë

¥¢¥Ð¥¿¡¼

¤½¤¦¤Ê¤ó¤Ç¤¹¤«¡©(((o(*Žß¢¦Žß*)o)))

¤â¤¦¡Ä²¿¤ò¿®¤¸¤Æ²¿¤òµ¿¤Ã¤Æ¤¤¤¤¤Î¤«¤¬¤ï¤«¤é¤Ê¤¯¤Ê¤Ã¤Æ¤·¤Þ¤¤¤Þ¤¹

ÆÌ

2014/10/22(¿å) ¸áÁ° 11:25 ¤­¤é¤­¤éÂç¹¥¤­

´é¥¢¥¤¥³¥ó

¤³¤ó¤Ë¤Á¤Ï

¤¤¤Ä¤â¡¢µ®½Å¤Ê¥³¥á¥ó¥ÈÍ­Æñ¤¦¤´¤¶¤¤¤Þ¤¹¡£
¤½¤¦¤Ç¤¹¤«¡©
±Ç²è¤ß¤¿¤¤¤Ç¤¹¤¬¡£¤Ç¤â¡¢Á᤯¼ý«¤·¤ÆÍߤ·¤¤¤Ç¤¹¡£

2014/10/23(ÌÚ) ¸á¸å 3:34 [ - ]

¥¢¥Ð¥¿¡¼

¤­¤é¤­¤é¤µ¤ó¡¢Î㤨¤ÐÆüËܤΥޥ¹¥á¥Ç¥£¥¢¤Îή¤¹¥Ë¥å¡¼¥¹¤Ï¤Û¤È¤ó¤ÉƱ¤¸¤Ç¤·¤ç¤¦¡£
¤¢¤ì¡¢Î®¤¹¥Ë¥å¡¼¥¹¤È¤½¤ÎÆâÍÆ¤ÎÅýÀ©¤ò¼õ¤±¤Æ¤¤¤ë¤«¤é¡£
¤½¤ì¤âÙÔ¤¤µ¤ì¤¿±ÇÁü¤âÇÛÉÛ¤µ¤ì¤ë¡£
¤Á¤ç¤Ã¤È¤Ç¤âµ¿Ìä¤òÊú¤¤¤¿¥Ë¥å¡¼¥¹¤Ë¤Ä¤¤¤Æ¤Ï¥Í¥Ã¥È¤Ç¸¡º÷¤·¤¿¤é¤¤¤¤¤Ç¤·¤ç¤¦¡£
ÆÃ¤Ë£²ch¤¬¤è¤¤¤«¤â¡£o(^¢¦^)o

2014/10/27(·î) ¸á¸å 4:29 ¿å̵À¥¤è¤ê

¥¢¥Ð¥¿¡¼

¥¢¥È¥ê¥¨m,°ì¿§¿¿ÃλҤµ¤ó¡¢±Ç²è²ñ¼Ò¤¬±Ç²è´ÆÆÄ¤Ëºî¤é¤»¤Æ¤¤¤ë¥±¡¼¥¹¤¬·ë¹½Â¿¤¤¤Î¤Ç¤¹¤è¡£
À¤³¦³ÆÔ¢¤¬¥ï¥¯¥Á¥ó¤ò¹ØÆþ¤·¤¿¤é¼ý«¤·¤Þ¤¹¡£¡³(¡­¢¦¡®)/

2014/10/27(·î) ¸á¸å 4:33 ¿å̵À¥¤è¤ê


.
¥¢¥Ð¥¿¡¼
¿å̵À¥¤è¤ê
Èó¸ø³« / Èó¸ø³«
¿Íµ¤ÅÙ
Yahoo!¥Ö¥í¥°¥Ø¥ë¥× - ¥Ö¥í¥°¿Íµ¤Å٤ˤĤ¤¤Æ
Æü ·î ²Ð ¿å ÌÚ ¶â ÅÚ
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

¥Ö¥í¥°¥Ð¥Ê¡¼

Yahoo!¤«¤é¤Î¤ªÃΤ餻

¸¡º÷ ¸¡º÷

²áµî¤Îµ­»ö°ìÍ÷

¥¹¥Þ¡¼¥È¥Õ¥©¥ó¤Ç¸«¤ë

¥â¥Ð¥¤¥ëÈÇYahoo!¥Ö¥í¥°¤Ë¥¢¥¯¥»¥¹¡ª

¥¹¥Þ¡¼¥È¥Õ¥©¥óÈÇYahoo!¥Ö¥í¥°¤Ë¥¢¥¯¥»¥¹¡ª

ɸ½à¥°¥ë¡¼¥×

¤è¤·¤â¤È¥Ö¥í¥°¥é¥ó¥­¥ó¥°

¤â¤Ã¤È¸«¤ë

[PR]¤ªÆÀ¾ðÊó

¤Õ¤ë¤µ¤ÈǼÀÇ¥µ¥¤¥È¡Ø¤µ¤È¤Õ¤ë¡Ù
¤ªÊÆ¡¢¤ªÆù¤Ê¤É¤Î¹¥¤­¤Ê¤ªÎéÉʤòÁª¤Ù¤ë
ËèÆü¿Íµ¤¥é¥ó¥­¥ó¥°¹¹¿·Ã桪
¤Õ¤ë¤µ¤ÈǼÀÇ¥µ¥¤¥È¡Ø¤µ¤È¤Õ¤ë¡Ù
11¡¿30¤Þ¤Ç£µ¼þǯµ­Ç°¥­¥ã¥ó¥Ú¡¼¥óÃæ¡ª
Amazon¥®¥Õ¥È·ô1000±ßʬÅö¤¿¤ë¡ª

¤½¤Î¾¤Î¥­¥ã¥ó¥Ú¡¼¥ó


¤ß¤ó¤Ê¤Î¹¹¿·µ­»ö